CXA-10

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
CXA-10
DrugBank Accession Number
DB15026
Background

CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 327.465
Monoisotopic: 327.240958547
Chemical Formula
C18H33NO4
Synonyms
  • 10-nitro-9(E)-octadec-9-enoic acid

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
1N19AGY57Y
CAS number
875685-46-4
InChI Key
WRADPCFZZWXOTI-BMRADRMJSA-N
InChI
InChI=1S/C18H33NO4/c1-2-3-4-5-8-11-14-17(19(22)23)15-12-9-6-7-10-13-16-18(20)21/h15H,2-14,16H2,1H3,(H,20,21)/b17-15+
IUPAC Name
(9E)-10-nitrooctadec-9-enoic acid
SMILES
CCCCCCCC\C(=C/CCCCCCCC(O)=O)[N+]([O-])=O

References

General References
Not Available
Human Metabolome Database
HMDB0062737
ChemSpider
21375709
BindingDB
50295049
ChEBI
86285
ChEMBL
CHEMBL561371
ZINC
ZINC000040331256

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
2CompletedTreatmentPrimary Focal Segmental Glomerulosclerosis (FSGS)1somestatusstop reasonjust information to hide
2RecruitingTreatmentAsthma / Obesity1somestatusstop reasonjust information to hide
2TerminatedTreatmentPulmonary Arterial Hypertension (PAH)3somestatusstop reasonjust information to hide
2WithdrawnTreatmentAsthma1somestatusstop reasonjust information to hide
1CompletedTreatmentAcute Kidney Injury (AKI)2somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000774 mg/mLALOGPS
logP5.26ALOGPS
logP5.97Chemaxon
logS-5.6ALOGPS
pKa (Strongest Acidic)4.99Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area80.44 Å2Chemaxon
Rotatable Bond Count16Chemaxon
Refractivity92.77 m3·mol-1Chemaxon
Polarizability39.06 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-8290000000-3b45586367964b741ff1
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-215.913996
predicted
DarkChem Lite v0.1.0
[M-H]-190.89299
predicted
DeepCCS 1.0 (2019)
[M+H]+216.226096
predicted
DarkChem Lite v0.1.0
[M+H]+193.25099
predicted
DeepCCS 1.0 (2019)
[M+Na]+216.646296
predicted
DarkChem Lite v0.1.0
[M+Na]+199.34413
predicted
DeepCCS 1.0 (2019)

Drug created at May 20, 2019 14:43 / Updated at September 12, 2023 18:32